Litcius/Paper detail

Postoperative Adjuvant Transarterial Infusion Chemotherapy with FOLFOX Could Improve Outcomes of Hepatocellular Carcinoma Patients with Microvascular Invasion: A Preliminary Report of a Phase III, Randomized Controlled Clinical Trial

Shaohua Li, Jie Mei, Qiaoxuan Wang, Zhixing Guo, Lianghe Lu, Yihong Ling, Li Xu, Minshan Chen, Lie Zheng, Wenping Lin, Jingwen Zou, Yuhua Wen, Wei Wei, Rong Guo

2020Annals of Surgical Oncology46 citationsDOI

Topics & Concepts

MedicineHepatocellular carcinomaHepatectomyClinical endpointInternal medicineRegimenFOLFOXRandomized controlled trialSurgical oncologyAdjuvantChemotherapyGastroenterologySurgeryAdverse effectCancerOxaliplatinColorectal cancerResectionHepatocellular Carcinoma Treatment and PrognosisOrgan Transplantation Techniques and OutcomesCholangiocarcinoma and Gallbladder Cancer Studies
Postoperative Adjuvant Transarterial Infusion Chemotherapy with FOLFOX Could Improve Outcomes of Hepatocellular Carcinoma Patients with Microvascular Invasion: A Preliminary Report of a Phase III, Randomized Controlled Clinical Trial | Litcius